Cargando…
Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334354/ https://www.ncbi.nlm.nih.gov/pubmed/34158421 http://dx.doi.org/10.14348/molcells.2021.4002 |
_version_ | 1783733051563442176 |
---|---|
author | Kwon, Hye Kyeong Choi, Hyunwoo Park, Sung-Gyoo Park, Woo Jin Kim,, Do Han Park, Zee-Yong |
author_facet | Kwon, Hye Kyeong Choi, Hyunwoo Park, Sung-Gyoo Park, Woo Jin Kim,, Do Han Park, Zee-Yong |
author_sort | Kwon, Hye Kyeong |
collection | PubMed |
description | Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites. However, functional studies of these differentially phosphorylated proteins have not been conducted in a large-scale or high-throughput manner due to a lack of methods capable of revealing the functional relevance of each phosphorylation site. In this study, an integrated approach combining quantitative phosphoproteomics and cell-based functional screening using phosphorylation competition peptides was developed. A pathological cardiac hypertrophy model, junctate-1 transgenic mice and control mice, were analyzed using label-free quantitative phosphoproteomics to identify differentially phosphorylated proteins and sites. A cell-based functional assay system measuring hypertrophic cell growth of neonatal rat ventricle cardiomyocytes (NRVMs) following phenylephrine treatment was applied, and changes in phosphorylation of individual differentially phosphorylated sites were induced by incorporation of phosphorylation competition peptides conjugated with cell-penetrating peptides. Cell-based functional screening against 18 selected phosphorylation sites identified three phosphorylation sites (Ser-98, Ser-179 of Ldb3, and Ser-1146 of palladin) displaying near-complete inhibition of cardiac hypertrophic growth of NRVMs. Changes in phosphorylation levels of Ser-98 and Ser-179 in Ldb3 were further confirmed in NRVMs and other pathological/physiological hypertrophy models, including transverse aortic constriction and swimming models, using site-specific phospho-antibodies. Our integrated approach can be used to identify functionally important phosphorylation sites among differentially phosphorylated sites, and unlike conventional approaches, it is easily applicable for large-scale and/or high-throughput analyses. |
format | Online Article Text |
id | pubmed-8334354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Korean Society for Molecular and Cellular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83343542021-08-11 Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites Kwon, Hye Kyeong Choi, Hyunwoo Park, Sung-Gyoo Park, Woo Jin Kim,, Do Han Park, Zee-Yong Mol Cells Research Article Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites. However, functional studies of these differentially phosphorylated proteins have not been conducted in a large-scale or high-throughput manner due to a lack of methods capable of revealing the functional relevance of each phosphorylation site. In this study, an integrated approach combining quantitative phosphoproteomics and cell-based functional screening using phosphorylation competition peptides was developed. A pathological cardiac hypertrophy model, junctate-1 transgenic mice and control mice, were analyzed using label-free quantitative phosphoproteomics to identify differentially phosphorylated proteins and sites. A cell-based functional assay system measuring hypertrophic cell growth of neonatal rat ventricle cardiomyocytes (NRVMs) following phenylephrine treatment was applied, and changes in phosphorylation of individual differentially phosphorylated sites were induced by incorporation of phosphorylation competition peptides conjugated with cell-penetrating peptides. Cell-based functional screening against 18 selected phosphorylation sites identified three phosphorylation sites (Ser-98, Ser-179 of Ldb3, and Ser-1146 of palladin) displaying near-complete inhibition of cardiac hypertrophic growth of NRVMs. Changes in phosphorylation levels of Ser-98 and Ser-179 in Ldb3 were further confirmed in NRVMs and other pathological/physiological hypertrophy models, including transverse aortic constriction and swimming models, using site-specific phospho-antibodies. Our integrated approach can be used to identify functionally important phosphorylation sites among differentially phosphorylated sites, and unlike conventional approaches, it is easily applicable for large-scale and/or high-throughput analyses. Korean Society for Molecular and Cellular Biology 2021-07-31 2021-06-23 /pmc/articles/PMC8334354/ /pubmed/34158421 http://dx.doi.org/10.14348/molcells.2021.4002 Text en © The Korean Society for Molecular and Cellular Biology. All rights reserved. https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ (https://creativecommons.org/licenses/by-nc-sa/3.0/) |
spellingShingle | Research Article Kwon, Hye Kyeong Choi, Hyunwoo Park, Sung-Gyoo Park, Woo Jin Kim,, Do Han Park, Zee-Yong Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites |
title | Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites |
title_full | Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites |
title_fullStr | Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites |
title_full_unstemmed | Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites |
title_short | Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites |
title_sort | integrated quantitative phosphoproteomics and cell-based functional screening reveals specific pathological cardiac hypertrophy-related phosphorylation sites |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334354/ https://www.ncbi.nlm.nih.gov/pubmed/34158421 http://dx.doi.org/10.14348/molcells.2021.4002 |
work_keys_str_mv | AT kwonhyekyeong integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites AT choihyunwoo integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites AT parksunggyoo integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites AT parkwoojin integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites AT kimdohan integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites AT parkzeeyong integratedquantitativephosphoproteomicsandcellbasedfunctionalscreeningrevealsspecificpathologicalcardiachypertrophyrelatedphosphorylationsites |